Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 13258-59-8, 2-ethyl-6-methylpyridin-3-ol hydrochloride, Emoxipin hydrochloride, 2-ethyl-6-methyl-3-pyridinol hydrochloride, 2-ethyl-3-hydroxy-6-methylpyridine hcl, 3-pyridinol, 2-ethyl-6-methyl-, hydrochloride
Molecular Formula
C8H12ClNO
Molecular Weight
173.64  g/mol
InChI Key
KZUIXWYHQJZUOK-UHFFFAOYSA-N
FDA UNII
SN1FWZ77AE

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-ethyl-6-methylpyridin-3-ol;hydrochloride
2.1.2 InChI
InChI=1S/C8H11NO.ClH/c1-3-7-8(10)5-4-6(2)9-7;/h4-5,10H,3H2,1-2H3;1H
2.1.3 InChI Key
KZUIXWYHQJZUOK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=C(C=CC(=N1)C)O.Cl
2.2 Other Identifiers
2.2.1 UNII
SN1FWZ77AE
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-ethyl-6-methyl-3-hydroxypyridine

2. 2-ethyl-6-methyl-3-oxypyridine

3. 6-methyl-2-ethyl-3-hydroxypyridine

4. 6-methyl-2-ethyl-3-hydroxypyridine Hydrochloride

5. 6-methyl-2-ethyl-3-hydroxypyridine Monohydrochloride

6. Emoxipin

7. Emoxipine

8. Emoxypin

9. Emoxypine

10. Epigid

11. Hydroxypyridine-6

2.3.2 Depositor-Supplied Synonyms

1. 13258-59-8

2. 2-ethyl-6-methylpyridin-3-ol Hydrochloride

3. Emoxipin Hydrochloride

4. 2-ethyl-6-methyl-3-pyridinol Hydrochloride

5. 2-ethyl-3-hydroxy-6-methylpyridine Hcl

6. 3-pyridinol, 2-ethyl-6-methyl-, Hydrochloride

7. Emoxypine Hydrochloride

8. 2-ethyl-3-hydroxy-6-methylpyridine Hydrochloride

9. Sn1fwz77ae

10. 2-ethyl-6-methylpyridin-3-ol;hydrochloride

11. Hydroxypyridine-6

12. 3-pyridinol, 2-ethyl-6-methyl-, Hydrochloride (1:1)

13. Sd 6 (antioxidant)

14. Op 6 (pharmaceutical)

15. Emoxipin Hcl

16. Mexidol Hydrochloride

17. Unii-sn1fwz77ae

18. Emoxypin Hydrochloride

19. Op-6

20. Schembl1373708

21. Dtxsid80157647

22. Bcp13397

23. Ck1206

24. Mfcd00460776

25. Akos005267199

26. Methylethylpiridinol Hydrochloride

27. Ds-15704

28. 2-ethyl-6-methylpyridin-3-olhydrochloride

29. Db-002447

30. Cs-0061447

31. Ft-0612241

32. 258e598

33. Methylethylpiridinol Hydrochloride [who-dd]

34. Q27289297

35. 3-hydroxy-6-methyl-2-ethylpyridine Hydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 173.64 g/mol
Molecular Formula C8H12ClNO
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass173.0607417 g/mol
Monoisotopic Mass173.0607417 g/mol
Topological Polar Surface Area33.1 Ų
Heavy Atom Count11
Formal Charge0
Complexity105
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Psychotropic Drugs

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)


Radiation-Protective Agents

Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)


Mutagens

Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)


Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)